MRI only conversion to multiple sclerosis following a clinically isolated syndrome

被引:33
作者
Chard, D. T. [1 ,2 ,3 ]
Dalton, C. M. [1 ,2 ,3 ]
Swanton, J. [1 ,2 ]
Fisniku, L. K. [1 ,2 ]
Miszkiel, K. A. [3 ]
Thompson, A. J. [2 ,3 ,4 ]
Plant, G. T. [3 ]
Miller, D. H. [1 ,2 ,3 ]
机构
[1] UCL Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England
[2] UCL Inst Neurol, NMR Res Unit, London WC1N 3BG, England
[3] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[4] UCL Inst Neurol, Dept Brain Repair & Rehabil, London WC1N 3BG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
DIAGNOSTIC-CRITERIA; OPTIC NEURITIS; MCDONALD CRITERIA; DISABILITY; DEFINITE; ABNORMALITIES; IMPAIRMENT; GUIDELINES; RISK; MS;
D O I
10.1136/jnnp.2010.208660
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Objectives Using current diagnostic criteria, patients who present with a clinically isolated syndrome (CIS) may develop multiple sclerosis (MS) by subsequently exhibiting dissemination in space and time on clinical (clinically definite (CD) MS) or radiological (MRI) grounds. This study investigated the frequency of radiological without clinical conversion to MS after long term follow-up as this has not previously been defined. Methods Two cohorts who underwent serial clinical and MRI studies from presentation with a CIS and who were followed-up over a mean of 6 and 20 years were investigated. The distribution and formation of lesions visible on brain MRI were assessed using the revised McDonald criteria (2005). Radiologically defined (RD) MS was determined by fulfilment of the MRI but not the CDMS criteria. Results 105 people were followed-up for 6 years after a CIS, of whom 51% developed CDMS, 15% RDMS and the remainder were classified as still having had a CIS. 70 people were followed-up at 20 years, of whom 61% and 11% had developed CDMS and RDMS, respectively. Conclusion About 10-15% of CIS patients may develop MS on MRI criteria only, without further clinical events for up to two decades.
引用
收藏
页码:176 / 179
页数:4
相关论文
共 24 条
[1]
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].
Brex, PA ;
Ciccarelli, O ;
O'Riordan, JI ;
Sailer, M ;
Thompson, AJ ;
Miller, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164
[2]
Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727
[3]
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial [J].
Comi, G. ;
Martinelli, V. ;
Rodegher, M. ;
Moiola, L. ;
Bajenaru, O. ;
Carra, A. ;
Elovaara, I. ;
Fazekas, F. ;
Hartung, H. P. ;
Hillert, J. ;
King, J. ;
Komoly, S. ;
Lubetzki, C. ;
Montalban, X. ;
Myhr, K. M. ;
Ravnborg, M. ;
Rieckmann, P. ;
Wynn, D. ;
Young, C. ;
Filippi, M. .
LANCET, 2009, 374 (9700) :1503-1511
[4]
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].
Comi, G ;
Filippi, M ;
Barkhof, F ;
Durelli, L ;
Edan, G ;
Fernández, O ;
Hartung, HP ;
Seeldrayers, P ;
Sorensen, PS ;
Rovaris, M ;
Martinelli, V ;
Hommes, OR .
LANCET, 2001, 357 (9268) :1576-1582
[5]
The natural history of multiple sclerosis: a geographically based study - 5. The clinical features and natural history of primary progressive multiple sclerosis [J].
Cottrell, DA ;
Kremenchutzky, M ;
Rice, GPA ;
Koopman, WJ ;
Hader, W ;
Baskerville, J ;
Ebers, GC .
BRAIN, 1999, 122 :625-639
[6]
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis [J].
Dalton, CM ;
Brex, PA ;
Miszkiel, KA ;
Hickman, SJ ;
MacManus, DG ;
Plant, GT ;
Thompson, AJ ;
Miller, DH .
ANNALS OF NEUROLOGY, 2002, 52 (01) :47-53
[7]
Eggenberger ER, 2004, ARCH NEUROL-CHICAGO, V61, P1538
[8]
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis [J].
Fisniku, L. K. ;
Brex, P. A. ;
Altmann, D. R. ;
Miszkiel, K. A. ;
Benton, C. E. ;
Lanyon, R. ;
Thompson, A. J. ;
Miller, D. H. .
BRAIN, 2008, 131 :808-817
[9]
Quantification of MRI lesion load in multiple sclerosis: A comparison of three computer-assisted techniques [J].
Grimaud, J ;
Lai, M ;
Thorpe, J ;
Adeleine, P ;
Wang, L ;
Barker, GJ ;
Plummer, DL ;
Tofts, PS ;
McDonald, WI ;
Miller, DH .
MAGNETIC RESONANCE IMAGING, 1996, 14 (05) :495-505
[10]
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].
Jacobs, LD ;
Beck, RW ;
Simon, JH ;
Kinkel, RP ;
Brownscheidle, CM ;
Murray, TJ ;
Simonian, NA ;
Slasor, PJ ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904